Sorcero, the AI-powered intelligence platform for life sciences, announced $42.5 million in Series B financing led by NewSpring Growth, NewSpring Capital's dedicated growth equity strategy that invests in fast-growing, industry-transforming technology companies. They are joined by Leawood Venture Capital and Blu Ventures, bringing the company's total capital raised to $59 million.

Sorcero是一家为生命科学领域提供人工智能支持的情报平台，宣布获得4250万美元的B轮融资，此轮融资由NewSpring Growth领投，这是NewSpring Capital专注成长型股权投资的策略，投资于快速增长、行业变革的技术公司。Leawood Venture Capital和Blu Ventures也参与其中，使该公司筹集的总资本达到5900万美元。

The latest funding allows Sorcero to accelerate expansion across medical affairs, safety, scientific communications, and medical device segments globally, continue scaling its platform for a medical-insights driven engagement model, and meet life sciences' critical need to drive adoption of breakthrough therapies..

最新一轮融资使Sorcero能够加速在全球医学事务、安全、科学传播和医疗器械领域的扩展，继续扩大其以医学洞察为导向的参与模式的平台规模，并满足生命科学领域对推动突破性疗法采用的关键需求。